<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04600375</url>
  </required_header>
  <id_info>
    <org_study_id>261683</org_study_id>
    <nct_id>NCT04600375</nct_id>
  </id_info>
  <brief_title>Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa</brief_title>
  <official_title>Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arkansas</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being conducted to evaluate if a written action plan for hidradenitis&#xD;
      suppurativa (HS) will help patients with hidradenitis suppurativa gain a better understanding&#xD;
      of the condition and how to manage the condition on a daily basis compared to a routine&#xD;
      verbal consultation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 20, 2020</start_date>
  <completion_date type="Actual">December 7, 2020</completion_date>
  <primary_completion_date type="Actual">December 7, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visits to high-cost care settings [ Time Frame: 12 months ]</measure>
    <time_frame>12 months</time_frame>
    <description>Number of visits to ER, urgent care, or hospitalizations because of HS</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Hidradenitis Suppurativa</condition>
  <arm_group>
    <arm_group_label>Verbal Consultation, then Written Action Plan</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>CONTROL GROUP&#xD;
Survey A&#xD;
Routine clinic visit&#xD;
Verbal consultation only&#xD;
Survey B&#xD;
Verbal consultation AND Written Action Plan&#xD;
Survey C</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental: Written Action Plan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>INTERVENTION GROUP&#xD;
Survey A&#xD;
Routine clinic visit&#xD;
Verbal consultation AND Written Action Plan&#xD;
Survey C</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Verbal consultation</intervention_name>
    <description>Verbal consultation only without written information before receiving written action plan</description>
    <arm_group_label>Verbal Consultation, then Written Action Plan</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Written Action Plan</intervention_name>
    <description>Written handout of treatment plan and disease management strategies</description>
    <arm_group_label>Experimental: Written Action Plan</arm_group_label>
    <arm_group_label>Verbal Consultation, then Written Action Plan</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  This study will only enroll subjects between the ages of 18-years and 89-years of age.&#xD;
&#xD;
          -  Diagnosis of HS by a board-certified dermatologist&#xD;
&#xD;
          -  Able to read and comprehend study materials&#xD;
&#xD;
          -  No prior exposure to written HS action plans&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Those who do not fit the inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vivian Y Shi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arkansas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>October 19, 2020</study_first_submitted>
  <study_first_submitted_qc>October 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2020</study_first_posted>
  <last_update_submitted>December 7, 2020</last_update_submitted>
  <last_update_submitted_qc>December 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hidradenitis Suppurativa</mesh_term>
    <mesh_term>Hidradenitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

